|
Fortis Healthcare (CRISIL) CRISIL Research fundamental grade |
| Date | Rating | Target Price | Recommendation Price | Broker house | | 15 Jul 2011 | 4/5 | 185 | 167 | CRISIL Report | |
|
Fortis Healthcare (Goldman Sachs) Hospital cash returns on an improving trajectory |
|
Incorporating SRL acquisition; Neutral | Date | Rating | Target Price | Recommendation Price | Broker house | | 7 Jul 2011 | neutral | 168 (from 166) | -- | Goldman Sachs Report | |
|
Fortis Healthcare (Citi) High Growth to Support Valuations |
|
Maintain Buy;Robust Growth Set to Continue;Entering Diagnostics;Healthy Balance Sheet to Aid Expansion;Revising Estimates, Maintain Target Price | Date | Rating | Target Price | Recommendation Price | Broker house | | 24 Jun 2011 | buy | 190 | 153 | Citi Report | |
|
Fortis Healthcare (ICICIsecurities) Margins impact on start-up costs of new hospitals |
|
Increase in capacity drives revenue growth; Margin declines on start-up costs |
|
Fortis Healthcare (JP Morgan) Incorporating SRL acquisition, raise PT to Rs175 |
|
SRL acquisition;Hospitals performance;FY11 results highlights | Date | Rating | Target Price | Recommendation Price | Broker house | | 31 May 2011 | neutral | 175 (from 160) | 162 | JP Morgan Report | |
|
fortis healthcare (ICICIsec) Meets Expectation |
|
fortis healthcare (Citi) No Major Surprises; Growth On Course |
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 8 Feb 2011 |
buy |
190 |
147 |
Citi Report |
Yahoo Link+NSE Link+Reuters Link+Reuters India Link+Google Link+DSR Search
Reports.DesiStockResearch.com |
|
fortis healthcare (Citi) Concerns Ease; Upgrade to Buy |
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 3 Dec 2010 |
buy (from sell) |
190 (from 145) |
153 |
Citi Report |
Yahoo Link+NSE Link+Reuters Link+Reuters India Link+Google Link+DSR Search Link
Reports.DesiStockResearch.com |
|
fortis healthcare (Citi) High Growth Phase |
|
fortis healthcare (ICICIsec) Parkway stake sale leads robust PAT growth |
